Corneal cross-linking in patients with keratoconus: up to 13 years of follow-up.

Christian EndersDiana VogelJens DreyhauptWaltraud WolfAylin Garip-KueblerJonathan HallLukas NeuhannJens Ulrich Werner

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)

CXL can slow down or even stop the progression of keratoconus in the majority of cases. The effect is long-lasting with excellent safety.

Keyphrases